BTC Health Ltd Asset Resilience Ratio
BTC Health Ltd asset resilience ratio. BTC Health Ltd (BTC) has an Asset Resilience Ratio of 14.52% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BTC defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of BTC Health Ltd (2004–2025)
Asset resilience ratio of BTC Health Ltd from 2004 to 2025. This chart shows how BTC Health Ltd's Asset Resilience Ratio has changed over time. Read BTC Health Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down BTC Health Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BTC total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$1.64 Million | 14.52% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$1.64 Million | 14.52% |
Asset Resilience Insights
- Moderate Liquidity: BTC Health Ltd has 14.52% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
BTC Health Ltd Industry Peers by Asset Resilience Ratio
Compare BTC Health Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653 |
Biotechnology | 1.69% |
|
Halozyme Therapeutics Inc
NASDAQ:HALO |
Biotechnology | 12.71% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Definium Therapeutics, Inc.
NASDAQ:DFTX |
Biotechnology | 38.51% |
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392 |
Biotechnology | 11.40% |
|
BB Biotech AG
SW:BION |
Biotechnology | 92.97% |
|
Zealand Pharma A/S
CO:ZEAL |
Biotechnology | 63.98% |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
Biotechnology | 4.69% |
BTC Health Ltd Asset Resilience Ratio by Year (2004–2025)
BTC Health Ltd asset resilience ratio by year from 2004 to 2025. The table below shows the annual Asset Resilience Ratio data for BTC Health Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 6.63% | AU$620.11K ≈ $438.77K |
AU$9.36 Million ≈ $6.62 Million |
-32.65pp |
| 2024-06-30 | 39.27% | AU$2.02 Million ≈ $1.43 Million |
AU$5.15 Million ≈ $3.64 Million |
-19.77pp |
| 2023-06-30 | 59.04% | AU$1.74 Million ≈ $1.23 Million |
AU$2.94 Million ≈ $2.08 Million |
+42.37pp |
| 2022-06-30 | 16.67% | AU$2.17 Million ≈ $1.54 Million |
AU$13.02 Million ≈ $9.21 Million |
-1.57pp |
| 2021-06-30 | 18.25% | AU$2.37 Million ≈ $1.68 Million |
AU$12.98 Million ≈ $9.19 Million |
-10.25pp |
| 2020-06-30 | 28.50% | AU$3.27 Million ≈ $2.31 Million |
AU$11.46 Million ≈ $8.11 Million |
-8.35pp |
| 2019-06-30 | 36.84% | AU$4.32 Million ≈ $3.06 Million |
AU$11.72 Million ≈ $8.29 Million |
-43.52pp |
| 2018-06-30 | 80.36% | AU$2.66 Million ≈ $1.89 Million |
AU$3.32 Million ≈ $2.35 Million |
+13.76pp |
| 2017-06-30 | 66.60% | AU$3.11 Million ≈ $2.20 Million |
AU$4.67 Million ≈ $3.30 Million |
+0.18pp |
| 2015-06-30 | 66.41% | AU$700.00K ≈ $495.29K |
AU$1.05 Million ≈ $745.76K |
-11.41pp |
| 2014-06-30 | 77.83% | AU$1.00 Million ≈ $707.56K |
AU$1.28 Million ≈ $909.13K |
-8.58pp |
| 2013-06-30 | 86.41% | AU$2.74 Million ≈ $1.94 Million |
AU$3.17 Million ≈ $2.24 Million |
+4.22pp |
| 2012-06-30 | 82.19% | AU$4.05 Million ≈ $2.87 Million |
AU$4.93 Million ≈ $3.49 Million |
+16.10pp |
| 2011-06-30 | 66.10% | AU$7.76 Million ≈ $5.49 Million |
AU$11.75 Million ≈ $8.31 Million |
+7.80pp |
| 2010-06-30 | 58.30% | AU$9.41 Million ≈ $6.66 Million |
AU$16.14 Million ≈ $11.42 Million |
+54.67pp |
| 2009-06-30 | 3.63% | AU$851.00K ≈ $602.14K |
AU$23.45 Million ≈ $16.59 Million |
-5.40pp |
| 2006-06-30 | 9.03% | AU$4.33 Million ≈ $3.06 Million |
AU$47.93 Million ≈ $33.91 Million |
-24.68pp |
| 2004-06-30 | 33.71% | AU$16.28 Million ≈ $11.52 Million |
AU$48.30 Million ≈ $34.18 Million |
-- |
About BTC Health Ltd
BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cel… Read more